Nasus Pharma Ltd.(NSRX)
Health Care
Medical - Pharmaceuticals
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-22 | Teleman Dan Benjamin Chief Executive Officer | Purchase | +6,550 | +4.17%163,541 | $3.10 | $20,305 | View SEC filing | |
| 2026-04-22 | Teleman Dan Benjamin Chief Executive Officer | Purchase | +2,900 | +1.88%156,991 | $3.76 | $10,904 | View SEC filing | |
| 2026-04-01 | Teleman Dan Benjamin Chief Executive Officer | Purchase | +15,000 | +240.15%21,246 | $2.04 | $30,600 | View SEC filing |
1-3 of 3